跳至主要内容
临床试验/NCT01887860
NCT01887860已完成不适用

Subject Repeat Insult Patch Test Skin Irritation/Sensitization Evaluation (Occlusive Patch)

Galderma R&D1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2012年12月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
Galderma R&D
入组人数
100
试验地点
1
主要终点
Area of erythema and edema measured

研究概览

简要总结

Determine if Cetaphil Daily Facial Moisturizer SPF 50 proves to be a contact sensitizer or irritant in certain individuals.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Not currently under a doctor's care
  • •Free of dermatological or systemic disorder which would interfere with the results
  • •Free of any acute or chronic disease
  • •Will complete a preliminary medical history form and are in general good health
  • •Can read, understand, and sign informed consent

排除标准

  • •Under 18 years old
  • •Currently under doctor's care
  • •Currently taking any medication
  • •History of acute or chronic disease
  • •Diagnosed with chronic skin allergies
  • •Pregnant or lactating

研究组 & 干预措施

Cetaphil Daily Facial Moisturizer SPF50

Experimental

All subjects receive Cetaphil Daily Facial Moisturizer SPF 50

干预措施: Cetaphil Daily Facial Moisturizer SPF 50 (Other)

结局指标

主要结局

Area of erythema and edema measured

时间窗: 3 consecutive weeks

9 consecutive 24hr exposures for every Monday, Wednesday, and Friday for 3 consecutive weeks

次要结局

未报告次要终点

研究者

发起方
Galderma R&D
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验